Court Rules Against Whistleblower in AbbVie Case: Regulatory Concerns Fall Short of False Claims Act Protection
SOUTH BEND, Ind. — The 7th Circuit Court of Appeals recently upheld a lower court’s dismissal of a lawsuit filed by Jeffrey Lewis against AbbVie Inc., previously known as Allergan. The court found that Lewis’s claims did not meet the necessary criteria under the False Claims Act, which addresses fraud against government programs. The case, officially designated as 24-3121, was initiated by Lewis in response to concerns he raised internally regarding AbbVie’s regulatory practices. However, the appeals court determined that these communications did not demonstrate any allegations of fraud, which is a key component for … Read more